4.8 Letter

Effectiveness of the BNT162b2 Covid-19 Vaccine against the B.1.1.7 and B.1.351 Variants

Journal

NEW ENGLAND JOURNAL OF MEDICINE
Volume 385, Issue 2, Pages 187-189

Publisher

MASSACHUSETTS MEDICAL SOC
DOI: 10.1056/NEJMc2104974

Keywords

-

Funding

  1. Biomedical Research Program
  2. Biostatistics, Epidemiology, and Biomathematics Research Core at Weill Cornell Medicine-Qatar
  3. Ministry of Public Health
  4. Hamad Medical Corporation
  5. Qatar Genome Program

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available